Article 9. Pharmaceutical industry development master plans
Law 105/2016/QH13 — Luật Dược số 105/2016/QH13
State policies on pharmacy and development of pharmaceutical industry
1. Pharmaceutical industry development master plans include those on manufacture, distribution, preservation and testing of drugs and drug materials, development of medicinal material sources and medicinal material culture and cultivation zones.
2. A pharmaceutical industry development master plan must satisfy the following requirements:
a/ Being compliant with this Law and other relevant laws;
b/ Being conformable with the national socio-economic development strategy in each period; contributing to environmental protection and sustainable development;
c/ Focusing on concentration, modernization and specialization;
d/ Containing scientific forecasts, meeting practical requirements and being in line with the development and international integration trend.
3. A master plan on development of production of medicinal materials, drugs from medicinal materials and traditional drugs or development of medicinal material sources and medicinal material culture and cultivation zones must satisfy the requirements prescribed in Clause 2 of this Article and the following requirements:
a/ Ensuring reasonable exploitation and use of natural resources; suitability to local soil, climate, ecological and other natural and social conditions;
b/ Setting orientations for the production and preparation of medicinal materials on an industrial scale, development of medicinal materials culture and cultivation zones, conservation of gene sources and development of precious, rare and endemic medicinal material species and varieties on the basis of increased investment in advanced techniques and technologies combined with traditional experiences.
4. The elaboration, approval and management of pharmaceutical industry development master plans must comply with law.
Article 9, Law 105/2016/QH13